← Leaderboards
Chuanxi Cai
University Of Louisville
$3,585,973
Attributed
$5,375,809
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $732.2K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,375,809 · 5
By mechanism
R01$4,587,927 · 2
R21$409,750 · 1
P20$378,132 · 2
Top collaborators
- Jianjie Ma4 shared
- Jacob Yount4 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Alexander Vladimirovich Ovechkin$6,601,597
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacRepairedMolecularMuscleHeartCellsMyocardial IschemiaMediatingInfarctionPlayGenesCardiomyopathiesHeart FunctionMyocardiumOxidative StressMyocardial InfarctionMyocardialImmunohistochemistryBaseRegenerative MedicineGrantCardiac MyocytesEchocardiographyReperfusion Injury
Grant awards (15)
Protein therapy to treat virus induced cardiopulmonary injury$655,228
R01 · FY2025 · HL
Protein therapy to treat virus induced cardiopulmonary injury$642,124
R01 · FY2024 · HL
Protein therapy to treat virus induced cardiopulmonary injury$655,228
R01 · FY2023 · HL
Protein therapy to treat virus induced cardiopulmonary injury$732,174
R01 · FY2022 · HL
Enhancing the effectiveness of human cardiac stem cell therapy$349,204
R01 · FY2016 · HL · contact PI
Enhancing the effectiveness of human cardiac stem cell therapy$45,795
R01 · FY2016 · HL · contact PI
Enhancing the effectiveness of human cardiac stem cell therapy$389,075
R01 · FY2015 · HL · contact PI
Enhancing the effectiveness of human cardiac stem cell therapy$387,100
R01 · FY2014 · HL · contact PI
Enhancing the effectiveness of human cardiac stem cell therapy$192,071
R01 · FY2013 · HL · contact PI
Enhancing the effectiveness of human cardiac stem cell therapy$164,928
R01 · FY2013 · HL · contact PI
Enhancing the effectiveness of human cardiac stem cell therapy$375,000
R01 · FY2012 · HL · contact PI
MG53 mediated myocardial repair for ischemic heart disease$186,250
R21 · FY2011 · HL · contact PI
MG53 mediated myocardial repair for ischemic heart disease$223,500
R21 · FY2010 · HL · contact PI
MESENCHYMAL STEM CELL THERAPY FOR INFARCT PROJ 3 2009$184,504
P20 · FY2010 · RR · contact PI
MESENCHYMAL STEM CELL THERAPY FOR INFARCT$193,628
P20 · FY2009 · RR · contact PI